tradingkey.logo

AdvanSix Q4 sales rise

ReutersFeb 20, 2026 11:40 AM


Overview

  • Integrated chemistry firm's Q4 revenue rose 9% yr/yr, driven by higher sales volume

  • Adjusted EPS for Q4 was $0.03, down from previous year

  • Company completed planned plant turnarounds, focusing on cost savings and cash flow


Outlook

  • AdvanSix expects 2026 capital expenditures of $75 to $95 mln

  • Company anticipates cash flow benefits from 45Q carbon capture tax credits in 2026

  • AdvanSix sees continued strength in Plant Nutrients amid higher sulfur input costs


Result Drivers

  • SALES VOLUME INCREASE - Q4 sales volume rose 11% due to prior year impact of extended plant turnaround

  • PLANT TURNAROUNDS - Successful completion of planned plant turnarounds improved operational efficiency

  • RAW MATERIAL COSTS - Decrease in benzene and propylene costs impacted raw material pass-through pricing


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Beat

$359.95 mln

$340.75 mln (2 Analysts)

Q4 Adjusted EPS

Beat

$0.03

-$0.06 (2 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for AdvanSix Inc is $21.00, about 16.7% above its February 19 closing price of $18.00

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 5 three months ago

Press Release: ID:nBw8pqhHxa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI